BR0010968A - Pharmaceutical preparation, pharmaceutical packaging, treatment method and use of an estrogenically active substance and progestogenically active substance in the preparation of a medicine - Google Patents
Pharmaceutical preparation, pharmaceutical packaging, treatment method and use of an estrogenically active substance and progestogenically active substance in the preparation of a medicineInfo
- Publication number
- BR0010968A BR0010968A BR0010968-1A BR0010968A BR0010968A BR 0010968 A BR0010968 A BR 0010968A BR 0010968 A BR0010968 A BR 0010968A BR 0010968 A BR0010968 A BR 0010968A
- Authority
- BR
- Brazil
- Prior art keywords
- active substance
- preparation
- pharmaceutical
- substance
- medicine
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
"PREPARAçãO FARMACêUTICA, EMBALAGEM FARMACêUTICA, MéTODO DE TRATAMENTO E USO DE UMA SUBSTâNCIA ESTROGENICAMENTE ATIVA E SUBSTâNCIA PROGESTOGENICAMENTE ATIVA NA PREPARAçãO DE UM MEDICAMENTO". Terapia de substituição hormonal, que compreende uma série de doses diárias de uma preparação farmacêutica, com as doses sendo administradas contínua e consecutivamente em fases alternadas de três doses diárias, uma fase de atividade estrogênica relativamente dominante que compreende três doses diárias de uma substância que exibe atividade estrogênica equivalente a cerca de 1 mg por dia de 17<225>-estradiol por dia e uma fase de atividade progestagênica relativamente dominante de uma combinação de uma substância que exibe atividade estrogênica equivalente a cerca de 1 mg por dia de 17<225>-estradiol e uma substância que exibe atividade progestogênica equivalente a cerca de 90 <109>g por dia de norgestimato."PHARMACEUTICAL PREPARATION, PHARMACEUTICAL PACKAGE, METHOD OF TREATMENT AND USE OF A ESTROGENICALLY ACTIVE SUBSTANCE AND PROGESTOGENICALLY ACTIVE SUBSTANCE IN THE PREPARATION OF A MEDICINE". Hormone replacement therapy, which comprises a series of daily doses of a pharmaceutical preparation, with doses being administered continuously and consecutively in alternating phases of three daily doses, a relatively dominant phase of estrogenic activity comprising three daily doses of a substance that exhibits estrogenic activity equivalent to about 1 mg per day of 17 <225> -estradiol per day and a relatively dominant phase of progestogenic activity of a combination of a substance that exhibits estrogenic activity equivalent to about 1 mg per day of 17 <225> -estradiol and a substance that exhibits progestogenic activity equivalent to about 90 <109> g per day of norgestimate.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US1267099P | 1999-03-30 | 1999-03-30 | |
| PCT/CA2000/000315 WO2000059577A1 (en) | 1999-03-30 | 2000-03-22 | Low dose estrogen interrupted hormone replacement therapy |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR0010968A true BR0010968A (en) | 2002-02-13 |
Family
ID=21756133
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR0010968-1A BR0010968A (en) | 1999-03-30 | 2000-03-22 | Pharmaceutical preparation, pharmaceutical packaging, treatment method and use of an estrogenically active substance and progestogenically active substance in the preparation of a medicine |
Country Status (1)
| Country | Link |
|---|---|
| BR (1) | BR0010968A (en) |
-
2000
- 2000-03-22 BR BR0010968-1A patent/BR0010968A/en not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR029159A1 (en) | PHARMACEUTICAL PREPARATION, PACKAGE CONTAINING AND USE IN THE PREPARATION OF A USEFUL MEDICINAL PRODUCT IN HORMONAL REPLACEMENT THERAPY | |
| UA32636C2 (en) | Method for reducing cholesterol content in human blood serum | |
| HRP20070188A2 (en) | Pharmaceutical combination of ethinylestradiol and drospirenone for use as a contraceptive | |
| KR960706344A (en) | MEANS AND METHOD FOR HORMONAL CONTRACEPTION AND / OR THE TREATMENT OF ACNE | |
| ATE309798T1 (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING CANNABIDIOL DERIVATIVES | |
| ATE401892T1 (en) | USE OF PHARMACEUTICAL PREPARATIONS CONTAINING OXCARBAZEPINE IN THE FUTTING STATE | |
| RU2001129160A (en) | Intermittent hormone replacement therapy with low doses of estrogen | |
| BR9709934A (en) | Hormone replacement therapy kit and / or contraceptive use of daily dosage units consisting essentially of a progestogen and process of preparing a drug delivery system | |
| PT854705E (en) | METHOD OF THERAPY OF HORMONAL REPLACEMENT AND RESPECTIVE DISPENSER | |
| GEP20032925B (en) | Benzothiepines Having Activity As Inhibitors of Ileal Bile Acid Transport and Taurocholate Uptake | |
| BR9814837A (en) | Procedure and device for dosing a drug | |
| ES2191329T3 (en) | USE OF XANTOFILS IN MEDICINES FOR THE IMPROVEMENT OF THE DURATION OF MUSCLE FUNCTION OR THE TREATMENT OF DISORDERS OR MUSCULAR DISEASES. | |
| CO5261567A1 (en) | USE OF BIOGENIC STROGEN SULFAMATES IN A HORMONE REPLACEMENT THERAPY | |
| AR035946A1 (en) | PHARMACEUTICAL COMPOSITIONS TO USE IN THE TREATMENT OF DISORDERS IN WOMEN PERIMENOPAUSIC, MENOPAUSIC OR POSMENOPAUSIC, AND USES OF SUCH COMPOSITIONS FOR THE PREPARATION OF MEDICINES | |
| YU36401A (en) | Pharmaceutical composition for modified insulin sensitiser | |
| BR0009380A (en) | Improved cancer treatment with temozozomide | |
| JP2002540148A5 (en) | ||
| BR0107881A (en) | Fsh use infertility treatment | |
| BR0010968A (en) | Pharmaceutical preparation, pharmaceutical packaging, treatment method and use of an estrogenically active substance and progestogenically active substance in the preparation of a medicine | |
| RU2449796C9 (en) | Pharmaceutical combination of ethynylestradiol and drospirenone for using as contraceptive | |
| HRP20090256T1 (en) | Use of estradiolvalerate and dienogest for oral treatment of dysfunctional uterine bleeding in a contraceptive method | |
| AR049195A1 (en) | USE OF A COMBINATION OF ETHINYLESTRADIOL AND ACETATE OF CLORMADINONE FOR THE PREPARATION OF A MEDICINAL PRODUCT | |
| AR012638A1 (en) | USE OF PREGNAN-3-OL-20-ONAS FOR THE MANUFACTURE OF A USEFUL MEDICINAL PRODUCT TO PROVIDE PROGESTATIONAL THERAPY | |
| CA2336711C (en) | Blister containing a transdermal therapeutic system and a single dose form of administration | |
| AR109456A2 (en) | USE OF ET743 FOR THE PREPARATION OF A MEDICINAL PRODUCT FOR THE TREATMENT OF A HUMAN PATIENT AFFECTED BY CANCER THROUGH COMBINATION THERAPY |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07A | Technical examination (opinion): publication of technical examination (opinion) | ||
| B09B | Decision: refusal |
Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 8O, 13 E 25 DA LPI. |
|
| B09B | Decision: refusal |
Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL. |
|
| B15K | Others concerning applications: alteration of classification |
Ipc: A61K 31/565 (2006.01), A61P 5/24 (2006.01) |